STRESS MANAGEMENT AND REGULAR EXERCISE CAN HELP IMPROVE OVERALL WELL-BEING
5. Lifestyle Adjustments: Stress management and regular exercise can help improve overall well-being.
Pharmacological treatments Several classes of medications play essential roles in managing Crohn's disease: 1. Aminosalicylates: These anti-inflammatory drugs are typically used to treat mild to moderate Crohn's disease. Examples include mesalamine and sulfasalazine. Pharmacists can educate patients on proper dosing and potential side effects such as headache, nausea, and diarrhoea. 2. Corticosteroids: For acute flare-ups, corticosteroids like prednisone may be prescribed. Pharmacists can counsel patients on short-term use due to potential long-term side effects like bone thinning and weight gain. 3. Immunomodulators: Medications like azathioprine and methotrexate work by suppressing the immune system. Pharmacists play a pivotal role in monitoring patients for adverse effects and ensuring they understand the importance of regular blood tests. 4. Biologics: A significant breakthrough in
Crohn's disease treatment, biologics like infliximab and adalimumab target specific proteins in the immune system. Pharmacists are instrumental in managing these complex medications, addressing concerns, and ensuring adherence. 5. Antibiotics: In cases of infection or abscesses, antibiotics such as ciprofloxacin or metronidazole may be prescribed. Pharmacists can educate patients on the importance of completing the full course and potential interactions with other medications. 6. Pain Relievers: Non-prescription pain relievers like acetaminophen can help manage pain associated with Crohn's disease, but pharmacists should caution against non- steroidal anti-inflammatory drugs (NSAIDs) due to their potential to worsen symptoms.
Challenges in Crohn's Disease management While pharmacological treatments have improved the quality of life for many Crohn's disease patients, challenges persist. Patients may struggle with adhering to their medication due to complexity or concerns about side effects. Biologics and some other medications can be
expensive and side effects of treatments can be a barrier for patients.
Promising Developments The landscape of Crohn's disease treatment is continually evolving. Recent developments include: 1. Advanced Biologics: New biologic medications that target specific inflammatory proteins or pathways are being developed for Crohn’s disease, such as ustekinumab, vedolizumab, and risankizumab. These biologics may offer benefits for patients who do not respond to or lose response to anti-TNF therapies, which are the current standard of care. Some of these biologics have been approved for use in Crohn’s disease, while others are still undergoing clinical trials. 2. Personalized Medicine: Personalized medicine aims to tailor treatment to individual patients based on their genetic and environmental factors, disease phenotype, and biomarkers. This approach may help to predict treatment response, optimize drug selection and dosing, and avoid adverse effects. Several genetic and biomarker tests have been developed or are under investigation for Crohn’s disease, such as the NOD2 gene, the IBDchip, and the Prometheus test. However, more research is needed to validate their clinical utility and cost-effectiveness. 3. Gene Therapies: Gene therapies aim to correct or modify the genetic defects that contribute to Crohn’s disease, such as mutations in the NOD2, ATG16L1, or IRGM genes. These therapies may involve delivering healthy genes, editing defective genes, or silencing harmful genes using viral vectors, CRISPR-Cas9, or RNA interference. Gene therapies have the potential to offer long-term remission or cure for Crohn’s disease, but they also pose significant challenges and risks, such as immune reactions, off-target effects, and ethical issues. Gene therapies for Crohn’s disease are still in the preclinical or early clinical stages of development.
Crohn's disease is a challenging condition that affects millions of individuals worldwide. While it requires lifelong management, a combination of medications, dietary adjustments, and supportive care can significantly improve the quality of life for those with the condition. With our expertise and dedication, pharmacists can make a significant difference in the lives of those managing this chronic condition, ultimately helping patients achieve better health and well-being.
scottishpharmacist.com 41
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48
